MedTrace Logo

Analgesic Contribution of the Suprazygomatic Maxillary Nerve Block for Cleft Palate Surgery in Children

NCT04023825 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-03-23

No results posted yet for this study

Summary

This is a monocentric prospective randomized simple-blind designed study evaluating the superiority of the suprazygomatic maxillary nerve block in analgesia after cleft palate surgery compared with a control group. Every two hours, nurses systematically reassess the patient's pain and adjust the analgesic medications. Analgesic requirement, incidence of respiratory complications, re-feeding time and the duration of hospitalization are evaluated.

Conditions

  • Cleft Palate
  • Surgery

Interventions

DRUG

suprazygomatic maxillary nerve block

in the experimental group, each child will profit from the realization of a suprazygomatic maxillary nerve block.

Sponsors & Collaborators

  • Centre Hospitalier Universitaire, Amiens

    lead OTHER

Principal Investigators

  • Matthieu Miclo, MD · CHU Amiens

  • Emmanuel Lorne, Pr · CHU Amiens

  • Jérémie Garnier, MD · CHU Amiens

  • Marie Trujillo-Garcia, MD · CHU Amiens

  • Dimitri Santarelli, MD · CHU Amiens

  • Cica Carole Gbaguidi, MD · CHU Amiens

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
5 Months
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2022-07-01
Completion
2022-07-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04023825 on ClinicalTrials.gov